Key result
In patients with MINOCA, diabetes mellitus did not significantly increase in-hospital MACE (41.5% vs 33.9%, p=0.240), but significantly increased long-term MACE (51.9% vs 31.1%, p=0.004) and all-cause mortality.
Why the study?
Knowledge about the impact of diabetes mellitus on outcomes in patients with myocardial infarction with non-obstructive coronary arteries is limited.
Does diabetes mellitus increase the risk of adverse cardiovascular events in troponin-positive patients with non-obstructive coronary arteries?
Cohort (n=373)
No
Does diabetes mellitus increase the risk of adverse cardiovascular events in troponin-positive patients with non-obstructive coronary arteries?
In patients with MINOCA, the presence of diabetes mellitus is associated with significantly higher long-term rates of major adverse cardiovascular events and all-cause mortality, despite similar short-term in-hospital outcomes.
DM associated with higher long-term MACE in troponin-positive non-obstructive CAD; leaves open whether intensified management improves outcomes.
Background: Diabetes mellitus is a major cardiovascular risk factor for the development of coronary artery disease, but knowledge about the impact of diabetes mellitus on the outcome of patients with myocardial infarction with non-obstructive coronary arteries is limited. The aim of this study was to investigate the prognostic impact of diabetes mellitus on in- and out-of-hospital adverse events in troponin-positive patients with non-obstructive coronary arteries. Methods and Results: A total of 373 troponin-positive patients with non-obstructive coronary arteries between 2010 and 2021 at Bergmannsheil University Hospital Bochum were enrolled, including 65 diabetics and 307 nondiabetics. The median follow-up was 6.2 years. The primary study end point was a composite of in-hospital major adverse cardiovascular events (MACE). Secondary endpoints covered MACE during follow-up.Mean age of the study cohort was 62.9 years and 49.3 % were male. Although the overall rate of in-hospital MACE was higher in diabetics (41.5 %) than in non-diabetics (33.9 %), this difference did not reach statistical significance (p = 0.240). The in-hospital mortality rate was low in both groups, 0 % of diabetes group versus 2.9 % of non-diabetic patients. During follow-up, diabetic patients had a significantly higher rate of MACE (51.9 % vs. 31.1 %, p = 0.004) and a significantly higher all-cause mortality rate than non-diabetic patients (42.3 % vs. 20.1 %, p < 0.001). Conclusion: Our study reveals that the impact of diabetes mellitus on cardiovascular outcomes in troponin-positive patients with non-obstructive coronary arteries intensifies over the long term, leading to increased rates of both cardiovascular adverse events and overall mortality.
No takes yet. Share an insight, caveat, or question.
Kreimer et al. (2024) conducted a cohort in Myocardial infarction with non-obstructive coronary arteries (MINOCA) (n=373). Diabetes mellitus vs. Non-diabetic patients was evaluated on In-hospital major adverse cardiovascular events (MACE) (p=0.240). In patients with MINOCA, diabetes mellitus did not significantly increase in-hospital MACE (41.5% vs 33.9%, p=0.240), but significantly increased long-term MACE (51.9% vs 31.1%, p=0.004) and all-cause mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: